Shifa International Hospitals Limited (PSX:SHFA)
439.05
-10.59 (-2.36%)
At close: Sep 29, 2026
PSX:SHFA Revenue
In the fiscal year ending June 30, 2026, Shifa International Hospitals had annual revenue of 31.32B PKR with 11.98% growth. Shifa International Hospitals had revenue of 8.64B in the quarter ending June 30, 2026, with 21.70% growth.
Revenue
31.32B
Revenue Growth
+11.98%
P/S Ratio
0.89
Revenue / Employee
5.57M
Employees
5,627
Market Cap
27.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 31.32B | 3.35B | 11.98% |
| Jun 30, 2025 | 27.97B | 4.41B | 18.74% |
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.02B |
| GlaxoSmithKline Pakistan | 67.12B |
| The Searle Company | 36.81B |
| Highnoon Laboratories | 28.50B |
| AGP Limited | 27.70B |
| Ferozsons Laboratories | 22.68B |
| Citi Pharma | 13.84B |
| Macter International | 12.17B |